Meanwhile, the 10-year cumulative CBC incidence for the HR+/ERBB2– subtype was 4.8% vs 2.7% (P = .002) and for the HR–/ERBB2+ subtype was 6.1% vs 2.9% (P = .02) in the younger and older groups, respectively. This evidence concerns the gene ERBB2 and complete blood cell count.